| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 19.4× | −1.7× | |
| Price / Book | 2.3× | 2.0× | |
| Price / Sales | 2.0× | 4.0× | |
| Price / Free cash flow | 14.2× | −1.6× | |
| EV / EBITDA | 11.1× | −1.2× | |
| Earnings yield | 5.2% | −14.4% | |
| Free cash flow yield | 7.0% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,301.55 | +4.93% | $1.23T | 56.6× | 77.8% | +15.2% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $259.48 | +2.24% | $625.32B | 22.8× | 32.9% | +32.1% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $287.92 | +1.85% | $508.79B | 118.2× | −129.2% | +24.6% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $416.77 | +2.43% | $374.09B | 30.3× | 12.8% | +14.1% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $148.35 | +3.29% | $366B | 19.4× | 34.7% | +71.2% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $152.69 | +1.66% | $281.48B | 19.7× | 30.5% | +14.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $167.88 | +2.40% | $260.37B | 24.8× | 21.1% | −2.4% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $683.94 | +0.67% | $252.88B | 37.3× | 12.6% | +26.6% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $435.64 | +2.52% | $235.52B | 29.8× | 89.1% | +43.7% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $155.26 | +1.43% | $192.52B | 22.3× | 37.5% | +29.9% |
